Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works as a GLP-1 receptor agonist that slows stomach emptying and increases fullness signals to your brain, but the timeline for visible weight loss varies significantly between individuals. Most clinical data shows that meaningful weight reduction begins in the second to fourth week of consistent treatment, though appetite suppression—the first sign the medication is working—often appears within 3 to 5 days. Understanding what to expect at each stage helps you stay committed to your treatment plan while PlexusDx personalizes your compound to match your body's response.

First Week on Semaglutide: Initial Changes and Expectations

During your first 7 days of semaglutide treatment, your body begins adjusting to the medication's presence in your system. Most patients report reduced hunger signals, decreased cravings for sweet or high-fat foods, and a noticeably different relationship with eating—many describe feeling full after smaller portion sizes than before treatment. Some individuals experience mild nausea, fatigue, or digestive adjustments as their body adapts; these sensations typically diminish within the first week as your system stabilizes.

The scale may show minimal change in week one, and that is completely normal—semaglutide's primary action is neurological and metabolic, not immediately visible on a scale. Your first week is a critical baseline period where you establish your new eating patterns and monitor how your individual body responds to the medication. Staying well-hydrated, eating protein-rich foods, and tracking how you feel (not just weight) creates valuable data for PlexusDx to refine your treatment approach.

Weeks 2–4: When Measurable Weight Loss Typically Begins

Clinical trials and real-world data consistently show that the first visible weight loss becomes apparent between days 10 and 28 of semaglutide treatment. During this window, patients usually lose 1 to 3 pounds per week as the medication's appetite-suppressing effects combine with naturally reduced calorie intake and improved metabolic efficiency. This period marks the turning point where motivation increases because you see tangible proof that the medication is working for your body.

At week 4, most patients on semaglutide report eating 30 to 40 percent fewer calories without conscious restriction—the medication eliminates the mental and physical drive to eat beyond satiation. This is why PlexusDx patients achieve consistent results: the compounded semaglutide injection delivers the active compound without the cost or supply chains of brand-name Ozempic, making it sustainable for long-term weight management. Your dose may increase during this phase to optimize results, but your monthly price remains fixed at $149, honoring PlexusDx's commitment that your dose may need to go up—your price won't.

Months 2–3: Accelerating Weight Loss and Metabolic Shifts

By week 8 through 12 of semaglutide therapy, cumulative weight loss typically ranges from 5 to 12 pounds depending on starting weight, adherence, and individual metabolic factors. Your body has fully adapted to the medication's presence, hunger signals remain suppressed, and your food preferences often shift toward nutritious, whole foods as cravings for processed items fade. Many patients report improved energy levels and better sleep quality during this phase, signaling that the medication's metabolic benefits extend beyond appetite control.

During months 2 and 3, some patients begin their first dose increase if their response plateaus or if their healthcare provider determines that optimization is needed. PlexusDx's Precision Peptide Genetic Test—available as a $99 add-on after your first month—can identify genetic variants in GLP1R and GIPR pathways that predict optimal compound selection and dosing strategy, potentially accelerating results for your specific biology. This personalization explains why PlexusDx patients often report faster, more stable weight loss than those using one-size-fits-all protocols.

Long-Term Results: What to Expect Beyond 3 Months

Extensive clinical evidence demonstrates that semaglutide produces sustained weight loss through month 12 and beyond, with average total loss ranging from 10 to 22 percent of body weight depending on dosing consistency and lifestyle factors. Most patients continue losing 1 to 2 pounds per week through month 6, then experience slower but steady progress as their body adjusts to its new weight set point. Weight loss typically plateaus around month 12 to 18, at which point maintenance dosing sustains your results indefinitely—you do not need to stop the medication or risk rapid weight regain.

Real-world success with semaglutide depends on three factors: consistent injection frequency (weekly for standard dosing), adequate nutrition to preserve muscle mass, and sustainable lifestyle habits that support the medication's effects. PlexusDx patients maintain results long-term because compounded semaglutide at $149/month removes the affordability barrier that causes many patients to discontinue brand-name therapy. Your doctor can adjust your dose or switch you to PlexusDx's dual-compound GLP-Squared option (combining semaglutide and tirzepatide for synergistic effect) if your progress slows, ensuring your treatment remains optimized for your evolving needs.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Why does it take 2–4 weeks to see semaglutide weight loss if I feel full immediately?

Appetite suppression and calorie reduction begin within days, but weight loss requires a caloric deficit to accumulate over time. Your body needs approximately 1–2 weeks of consistent reduced intake to mobilize stored fat at a measurable rate. PlexusDx monitors this timeline with you during your first month to ensure your dose is optimized for visible results by week 4.

What clinical evidence supports these semaglutide weight loss timelines?

The STEP trials (Semaglutide Treatment Effect in People with obesity) followed thousands of patients weekly and documented that 55 percent of patients lost at least 5 percent of body weight by week 4, and 80 percent achieved this milestone by week 12. Real-world compounded semaglutide produces identical timelines because the active pharmaceutical compound is identical to brand-name formulations from licensed 503A pharmacies.

Does PlexusDx offer semaglutide at a lower cost than other telehealth providers?

PlexusDx compounded semaglutide injections start at $149 per month with no membership fees, no insurance required, and HSA/FSA eligibility—significantly lower than brand-name Ozempic copays or competitor pricing. Your price stays flat even if your dose increases, so you never pay more as your treatment optimizes.

Are there safety concerns if weight loss doesn't appear after 4 weeks?

If you experience no appetite suppression or weight change after 4 weeks, your body may have a genetic variant affecting GLP1R responsiveness. PlexusDx's Precision Peptide Genetic Test ($99 add-on) identifies these variants and can guide a switch to tirzepatide or a dual-compound approach, ensuring you achieve results safely and efficiently.

How does the PlexusDx Precision Peptide Genetic Test help predict my weight loss timeline?

The test analyzes 14 metabolic pathways including GLP1R (rs6923761) and GIPR (rs1800437) variants that directly influence how your body responds to semaglutide and tirzepatide. Patients with favorable genetic profiles often see measurable weight loss by week 2, while those with less responsive variants benefit from earlier dose increases or compound switches—information that PlexusDx uses to accelerate your personalized timeline.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves